Beare Paul A, Chen Chen, Bouman Timo, Pablo Jozelyn, Unal Berkay, Cockrell Diane C, Brown Wendy C, Barbian Kent D, Porcella Stephen F, Samuel James E, Felgner Philip L, Heinzen Robert A
Laboratory of Intracellular Parasites, Rocky Mountain Laboratories, 903 S. 4th St., Hamilton, MT 59840, USA.
Clin Vaccine Immunol. 2008 Dec;15(12):1771-9. doi: 10.1128/CVI.00300-08. Epub 2008 Oct 8.
Q fever is a widespread zoonosis caused by Coxiella burnetii. Diagnosis of Q fever is usually based on serological testing of patient serum. The diagnostic antigen of test kits is formalin-fixed phase I and phase II organisms of the Nine Mile reference strain. Deficiencies of this antigen include (i) potential for cross-reactivity with other pathogens; (ii) an inability to distinguish between C. burnetii strains; and (iii) a need to propagate and purify C. burnetii, a difficult and potentially hazardous process. Consequently, there is a need for sensitive and specific serodiagnostic tests utilizing defined antigens, such as recombinant C. burnetii protein(s). Here we describe the use of a C. burnetii protein microarray to comprehensively identify immunodominant antigens recognized by antibody in the context of human C. burnetii infection or vaccination. Transcriptionally active PCR products corresponding to 1,988 C. burnetii open reading frames (ORFs) were generated. Full-length proteins were successfully synthesized from 75% of the ORFs by using an Escherichia coli-based in vitro transcription and translation system (IVTT). Nitrocellulose microarrays were spotted with crude IVTT lysates and probed with sera from acute Q fever patients and individuals vaccinated with Q-Vax. Immune sera strongly reacted with approximately 50 C. burnetii proteins, including previously identified immunogens, an ankyrin repeat-domain containing protein, and multiple hypothetical proteins. Recombinant protein corresponding to selected array-reactive antigens was generated, and the immunoreactivity was confirmed by enzyme-linked immunosorbent assay. This sensitive and high-throughput method for identifying immunoreactive C. burnetii proteins will aid in the development of Q fever serodiagnostic tests based on recombinant antigen.
Q热是一种由伯氏考克斯体引起的广泛传播的人畜共患病。Q热的诊断通常基于对患者血清的血清学检测。检测试剂盒的诊断抗原是九英里参考菌株的福尔马林固定的I相和II相菌体。这种抗原的不足之处包括:(i)与其他病原体发生交叉反应的可能性;(ii)无法区分伯氏考克斯体菌株;(iii)需要培养和纯化伯氏考克斯体,这是一个困难且有潜在危险的过程。因此,需要利用确定的抗原,如重组伯氏考克斯体蛋白,进行灵敏且特异的血清学诊断检测。在此,我们描述了使用伯氏考克斯体蛋白微阵列来全面鉴定在人类伯氏考克斯体感染或疫苗接种情况下被抗体识别的免疫显性抗原。生成了与1988个伯氏考克斯体开放阅读框(ORF)相对应的转录活性PCR产物。通过基于大肠杆菌的体外转录和翻译系统(IVTT),成功从75%的ORF中合成了全长蛋白。用粗制的IVTT裂解物点样于硝酸纤维素微阵列上,并用急性Q热患者和接种Q-Vax疫苗个体的血清进行检测。免疫血清与大约50种伯氏考克斯体蛋白强烈反应,包括先前鉴定的免疫原、一种含锚蛋白重复结构域的蛋白以及多种假定蛋白。生成了与选定的阵列反应性抗原相对应的重组蛋白,并通过酶联免疫吸附测定法确认了免疫反应性。这种用于鉴定伯氏考克斯体免疫反应性蛋白的灵敏且高通量的方法将有助于基于重组抗原的Q热血清学诊断检测的开发。